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Outbreaks pose a significant risk to patient safety as well as being costly and time con-
suming to investigate. The implementation of targeted infection prevention and control
measures relies on infection prevention and control teams having access to rapid results
that detect resistance accurately, and typing results that give clinically useful information
on the relatedness of isolates. At present, determining whether transmission has occurred
can be a major challenge. Conventional typing results do not always have sufficient
granularity or robustness to define strains unequivocally, and sufficient epidemiological
data are not always available to establish links between patients and the environment.
Whole-genome sequencing (WGS) has emerged as the ultimate genotyping tool, but has
not yet fully crossed the divide between research method and routine clinical diagnostic
microbiological technique. A clinical WGS service was officially established in 2014 as part
of the Scottish Healthcare Associated Infection Prevention Institute to confirm or refute
outbreaks in hospital settings from across Scotland. This article describes the authors’
experiences with the aim of providing new insights into practical application of the use of
WGS to investigate healthcare and public health outbreaks. Solutions to overcome barriers
to implementation of this technology in a clinical environment are proposed.
ª 2020 The Authors. Published by Elsevier Ltd
on behalf of The Healthcare Infection Society. This is an open access article
under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Introduction
Whole-genome sequencing (WGS) has several advantages
over conventional microbiological typing techniques. It can be
applied to all micro-organisms (bacteria, fungi, viruses andls Hospital and Medical
382 632855; fax: þ44(0)
t (B.J. Parcell).
iences, Bristol Medical
Elsevier Ltd on behalf of The
mons.org/licenses/by/4.0/).parasites) and used to analyse their entire genomes [1]. Since
Sanger et al. sequenced the first complete DNA genome
(bacteriophage fX174) using the ‘plus and minus’ method in
1977, advances in this field have resulted in increased
capacity, reduced costs, and improved speed and reproduci-
bility of results, all of which present an opportunity for WGS to
be further incorporated into routine microbiological work-
flows [2e5]. WGS can be used to pinpoint and track bacteria to
a greater degree than traditional typing methods, and has
been applied to the investigation of a wide variety of out-
breaks [6e8]. WGS has also been used to investigate theHealthcare Infection Society. This is an open access article
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Figure 1. Incorporation of whole-genome sequencing (WGS) into conventional outbreak analysis workflows for in-silico outbreak
investigation. IPC, infection prevention and control; SPC, statistical process control; PCR, polymerase chain reaction.
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nanopore DNA sequencing technology in the form of the Min-
ION (Oxford Nanopore Technologies, Oxford, UK) was utilized
for real-time genome sequencing of the Ebola virus disease
epidemic in West Africa and yellow fever virus in Brazil [9,10].
The Zika genome has also been sequenced directly from
clinical samples using a protocol involving multiplex poly-
merase chain reaction (PCR) for MinION and Illumina
sequencing [11]. More recently, a combined phylogenetic and
epidemiological approach was undertaken using Oxford
Nanopore and Illumina MiSeq technology to investigate the
first 4 weeks of emergence of severe acute respiratory syn-
drome coronavirus-2 in Scotland [12].
In recent years, reference laboratories have adopted WGS
as a standard typing technique for Escherichia coli, Shigella
spp., Listeria spp., Campylobacter spp., Staphylococcus
aureus, Salmonella spp. and Mycobacterium spp. [13]. In the
case of Salmonella spp., WGS has emerged as an alternative
to the previous gold standard of traditional serology and the
KauffmanneWhite scheme [14]. Single nucleotide poly-
morphism (SNP)-based genetic cluster analysis can also be
performed to inform epidemiological investigations, such as
the UK-wide Salmonella enteritidis 25-SNP cluster t25.12
outbreak and national surveillance [15]. Newer bioinformatic
methods offer results with improved accuracy, reproduci-
bility and greater resolution. With advances in sequencing
technology, there is greater potential to utilize sequencing
for real-time outbreak investigations to inform infection
prevention and control (IPC) interventions. Greater knowl-
edge and understanding of the transmission of micro-
organisms can be generated to inform the best ways to pre-
vent the dissemination of antimicrobial resistance. Consid-
eration must be given as to how best to refine this potentially
disruptive technology, optimizing its use in clinical settings
so that results are timely, clinically relevant and interpret-
able by the outbreak management team. This article con-
siders how WGS could be used in the investigation of
outbreaks in the future. By using examples from the authors’
experience of applying WGS as a targeted IPC tool, this
article will illustrate the benefits of harnessing the discrim-
inatory power of WGS in outbreak investigations. In doing so,
the aim is to provide pointers towards potential solutions
when faced with the challenges brought by this new tech-
nology. Over a 5-year period, the authors established a WGS
service, with no prior infrastructure, to confirm or refute
nosocomial outbreaks in real-time in NHS clinical environ-
ments. Clinical specimens were first collected as part of
routine care, and initially processed in National Health
Service microbiology laboratories using standard methods
prior to sequencing by the Infection and Global Health Divi-
sion, University of St Andrews (Figure 1). Over 3 years, 761
isolates from more than 20 nosocomial outbreaks from health
boards across Scotland were sequenced. The pathogens
sequenced included: Acinetobacter baumanii, Enterobacter
cloacae, Enterococcus faecalis, Enterococcus faecium,
E. coli, Klebsiella oxytoca, Klebsiella pneumoniae, Listeria
monocytogenes, Morganella morganii, Mycobacterium
abscessus, Pseudomonas aeruginosa, Enterobacter asburiae,
Serratia marcescens, S. aureus, Staphylococcus epidermidis
and Streptococcus pyogenes.The value of results with greater granularity due
to WGS
It is recognized that routine typing results can obstruct out-
break investigations when results are not rapid, and also when
they are unable to show unequivocally whether or not isolates
are linked. Pulsed-field gel electrophoresis (PFGE) was pre-
viously considered by many to be the gold standard for micro-
biological typing; however, although it was standardized
internationally, it could not decipher evolutionary relationships,
or determine whether isolates were truly related in terms of
transmission having taken place following identification of a
prevalent profile [16,17] Multi-locus sequence typing, which
interrogates regions of 400e500 bp from multiple (usually
seven) housekeeping genes, is highly reproducible, standardized
and easily comparable between laboratories, but lacks dis-
criminatory power for deep epidemiological surveillance [16].
Previously, the authors illustrated the relative discriminatory
power of WGS when used for the investigation of an outbreak of
P. aeruginosa involving nine patients in an adult intensive care
unit (ICU) [18]. Both variable number of tandem repeats (VNTR)
and PFGE were required to fully determine that transmission
had occurred between handwash basin water and two patients.
The use of WGS would have provided the necessary information
in one step, negating the need for further typing.
WGS can assist IPCTs when routine typing fails to
determine whether or not bacterial isolates are
linked due to the commonality of distribution of
pathogen types
WGS was used to assist the outbreak team [infection pre-
vention and control team (IPCT) and public and environmental
health team] in a hospital outbreak investigation of two cases
of invasive listeria infection. L. monocytogenes is a notifiable
foodborne pathogen which can cause gastroenteritis. Early
identification of the source is essential in order to prevent
further transmission to patients, staff and the public as lis-
teriosis has a crude mortality rate of 20% and is associated with
sepsis, meningoencephalitis and, in pregnant patients, abor-
tion or premature delivery [17]. In this investigation, both
patients were immunocompromised and had been admitted to
hospital at various points. Routine typing identified the listeria
isolates as serotype 4 [clonal complex (CC) 1 and sequence type
(ST) 1]. Hospital-wide and ward catering facilities had been
inspected and no concerns regarding the practice of food
hygiene had been noted. The outbreak team were unsure
whether there had been transmission as this was one of the
more common serotypes found in clinical isolates (one in six
invasive listeria isolates are CC1), and consensus opinion
amongst the outbreak management team had been that further
catering facility inspections were not required. Both listeria
isolates underwent WGS. Reads were initially mapped to the
reference chromosome of strain F2365, and SNPs were identi-
fied against this. The two isolates were found to be indis-
tinguishable, and therefore highly likely to be
epidemiologically linked. In this example, WGS revealed addi-
tional information that prompted further action to look again
for a common link. The outbreak team repeated hospital
B.J. Parcell et al. / Journal of Hospital Infection 109 (2021) 1e94kitchen inspections, and as a result of this identified that the
handling of salads and meat did not meet national recom-
mendations. Subsequently, hospital catering facilities were
closed temporarily until remedial action was undertaken. A
further case of invasive serotype 4 listeria infection was iden-
tified in a patient 5 months later. WGS ruled this isolate out of
the outbreak as it was found to differ by approximately 10,000
SNPs, illustrating that it was too genetically divergent to share
a recent common ancestry with the earlier cluster.
Enhancing the detection of ‘alert organisms’
using genomic analysis
Some countries have an agreed minimum list of micro-
organisms that are deemed to pose a risk to patients due to
antimicrobial resistance and/or virulence. Flagging up alert
organisms such as these allows IPCTs to perform further
investigations [19]. The detection of alert bacteria and fungi
from patient and/or environmental samples in clinical micro-
biology laboratories traditionally relies upon the use of phe-
notypic methods. If the same alert organism is identified from
the samples of multiple patients taken within the sameBasis for phylogenetic an
discriminatory power i
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Figure 2. Basis for phylogenetic analysis and increased whole-genome
BORSA, borderline oxacillin-resistant Staphylococcus aureus; MRSA
Enterococcus faecium; VREfm, vancomycin-resistant E. faecium; CP
spectrum beta-lactamase.timeframe and in a similar place, an outbreak investigation is
usually initiated and bacterial isolates will be sent for typing.
Statistical process control (SPC) charts can also be used to
demonstrate how outbreak strains can accumulate. They dis-
play data chronologically and can reveal natural or unnatural
variation [20]. However, using approaches which focus solely
on alert micro-organisms to detect transmission does not
account for the fact that there can be dissemination of genetic
elements, such as transposons and plasmids carrying antibiotic
resistance genes. This can be a dynamic process, and tradi-
tional typing may lack the discriminatory power to identify the
genetic lineage of isolates beyond species. This could poten-
tially result in the failure of IPC measures if an alert organism is
misidentified or not detected. To explain this point, the ben-
efits of using genomic analysis to detect alert organisms rather
than solely accepting results from phenotypic tests was high-
lighted in the investigation of a seemingly small separate series
of vancomycin-resistant E. faecium (VREfm) outbreaks. Ini-
tially, VREfm was identified in urine cultures from two patients
admitted to the same ward of an orthopaedic rehabilitation
hospital. Antibiograms were identical, and further screening
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e one identified from rectal swabs and another from urine e
and each strain was related to an entirely different outbreak
cluster in the main hospital. This demonstrated the importance
of repeated and sequential patient sampling from different
body sites, including multiple colonies for sequencing during an
enterococcus outbreak investigation. Over a 2-year period,
further positive patients were identified on the surgical high
dependency unit and renal ward of the main hospital, totalling
11 cases. Routine PFGE typing of all the VREfm isolates from all
patients revealed five separate clusters in total (three ST80
clusters, one ST64 culture and one ST203 cluster). When WGS
was applied, it revealed that, in fact, there was only one ST80
cluster, rather than numerous discrete clusters as reported by
PFGE. There was a difference of 65e77 SNPs between isolates
taken from various patients, suggesting a recent common
ancestor (i.e. within the last 5 years). The value of WGS to
unravel the transmission pathways was demonstrated when
two vancomycin-susceptible E. faecium (VSEfm) isolates from









Figure 3. Recommendations for using whole-genome sequencing (W
acquired infection; MRSA, meticillin-resistant Staphylococcus aureus;outbreak in the ICU the preceding year, were linked to the ST64
cluster. This was an unexpected finding, uncovering a hidden
transmission event of which the IPCT was not aware. The four
isolates were differentiated by only 21 SNPs, suggesting a rel-
atively recent common source. The investigation also revealed
that interhospital transmission had occurred between local
hospitals and a regional hospital performing renal transplants.
These results were produced as part of a real-time VREfm
outbreak investigation, and support findings from a retro-
spective study in the UK in which Raven et al. applied WGS to
the genetic characterization of 293 bacteraemia isolates [21].
They found that the majority of bacteraemias were hospital-
acquired or healthcare-associated, and over 50% of isolates
were highly related. In 32% of cases, complex transmissions had
occurred over a number of years and across various wards,
there was a mixture of vancomycin-resistant and vancomycin-
susceptible antibiotic profiles, and this was due to isolates
having lost or gained transposons carrying the gene encoding
vancomycin resistance (vanA) [21]. Taken together, these
findings indicate that resistance in enterococci is not stable,e
e
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mission is not reliable. IPCTs therefore need to consider alert
organisms in the context of background dissemination of
genetic elements in their hospital. For instance, if an increase
in the number of cases of enterococcal bacteraemia has been
detected, it may be necessary to move quickly to deploy
pathogen sequencing to type isolates, irrespective of whether
isolates are VSEfm or VREfm.
Streamlining outbreak investigations in the laboratory
WGS can aid the in-silico investigation of outbreaks by
improving turnaround times of results, thereby rapidly
streamlining outbreak investigations. It can also be used to
replace unnecessary routine laboratory testing, and reduce the
transport of isolates to various reference laboratories for tra-
ditional typing. Carbapenemase-producing Enterobacterales
are notoriously challenging to detect in clinical laboratories,
and multiple methods are routinely used to detect them. In an
outbreak involving three renal patients infected with blaKPC-
positive ST258 K. pneumoniae, WGS was found to negate the
need for screening by various multiplex PCR assays in two dif-
ferent laboratories and VNTR analysis. Additionally, WGS
revealed that one of the samples was mixed with an ST3 E. coli
which had not been identified on routine testing.
Ruling out outbreaks with WGS
WGS can also be used by IPCTs to rule out outbreaks,
avoiding disruption to services by removing the need for staff
and time-consuming outbreak meetings. If WGS can be used to
rule out an outbreak, staff can focus on preventive measures
and tasks which could stop the occurrence of outbreaks. There
would be additional benefits to the hospital and patients as
outbreak control measures could be stopped, wards could
open, and patients would not require screening. Extra cleaning
regimes, such as twice-daily cleaning of commonly touched
surfaces with chlorine disinfectant, with increased domestic
staff input would not be necessary. In one example illustrating
these points, a doctor highlighted that they had noticed three
separate patients who had extended-spectrum beta-lacta-
mase-positive E. coli urine cultures with identical antibio-
grams. The patients resided in a residential care home, and the
doctor was concerned that this may represent a breakdown in
IPC measures. An outbreak was suspected by the IPCT as an
alert organism had been detected from the samples of three
separate patients taken within the same timeframe. In this
situation, the three isolates underwent WGS and were mapped
to ST43 (ST131) reference chromosome sequence from an iso-
late that originated in the UK. Looking at the core genome,
differences ranged from 99 SNPs to 162 SNPs, providing reas-
surance that this was not an outbreak.
Using WGS to uncover new resistance
mechanisms
An essential part of IPC is horizon scanning: identifying new
threats including new pathogens and resistance mechanisms.
Aside from its utility for high-resolution SNP-based typing, WGS
can capture the whole-genome inventory of an organism, and
can therefore be used as a vital tool for the investigation ofemerging resistance mechanisms. optrA is an ABC transporter
gene, first reported in 2015, that encodes resistance to oxa-
zolidinones such as linezolid via active efflux [22]. National
resistance alerts have been issued highlighting the risk to
public health as this new resistance mechanism is plasmid-
mediated and could potentially transfer to other strains, spe-
cies and genera present on the skin and gut of humans and
animals [23]. In 2016, an IPCT investigation was undertaken as
Public Health England’s Antimicrobial Resistance and Health-
care Associated Infections Reference Unit confirmed a patient
had a urine sample which was positive for optrA linezolid-
resistant enterococcus. A retrospective search of the hospi-
tal’s historical laboratory culture results identified two further
patients with E. faecalis isolates that were linezolid resistant,
identified in 2014 and 2015. WGS was applied to investigate
these isolates and found that both were positive for the optrA
gene. A review of the epidemiology revealed that all patients
had urinary tract infections. WGS was valuable in this situation
as it identified that the isolates were of three distinct sequence
types (ST480, ST19 and ST330), confirming that resistance had
emerged separately in the E. faecalis population.Barriers and facilitators to translating the
promise of WGS into clinical practice
This article has identified some of the barriers and facili-
tators to translating the promise of WGS into clinical practice in
a system-based manner. The first barrier to integration of WGS
into conventional outbreak analysis in any clinical microbiology
laboratory is infrastructure. Options include placing equipment
at national reference laboratories, at hub sites (e.g. large
teaching hospitals) or outsourcing to private laboratories.
However, the continued progress of sequencing technology has
enabled clinical microbiology laboratories to come a step
closer to performing low-cost WGS themselves, using simple
bench-top technology and user-friendly library preparation
protocols [24]. Benefits of placing facilities closer to patients
include streamlining of work (replacement of multiple tests
and reduction in sending samples away for confirmatory test-
ing) which could result in reduced turnaround times. However,
if WGS is incorporated into local teaching hospital facilities,
there would need to be investment in appropriately trained
staff, equipment and data analysis. It should also be considered
that the future of clinical microbiology is changing and less
conventional microbiology is being undertaken. There has been
increased use of molecular methods such as PCR, point-of-care
testing and automation. Staff skill mix is changing; for
instance, consultant microbiologists are carrying out less
authorization of routine results, and more staff are familiar
with DNA extraction and PCR techniques. This could present an
opportunity for WGS to be utilized within clinical microbiology
services. To increase the success of a business case, the
potential impact of WGS on patient management should be
included. This could include its impact on antimicrobial stew-
ardship, IPC measures, outbreak investigation and subsequent
impact on services. To further strengthen a business case, WGS
facilities could be shared with other departments, such as
human genetics or a university department, provided that
appropriate approvals are in place. Regardless of location,
laboratories need to assure the quality of WGS and validate
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Figure 4. Whole-genome sequencing (WGS) clinical decision aid. HAI, hospital-acquired infection; IPC, infection prevention and control;
SPC, statistical process control; MRSA, meticillin-resistant Staphylococcus aureus; PCR, polymerase chain reaction; VRE, vancomycin-
resistant enterococci; SCBU, special care baby unit; MLST, multi-locus sequence typing; iGAS, invasive group A streptococcal disease.
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accredited by the United Kingdom Accreditation Service.
Additional guidance for sharing genomic data needs to be
developed so that patient privacy is maintained yet genomic
sequences can be shared and used in an early warning system
for outbreaks. Thought must be given to producing an action-
able result within a useful timeframe, and it is essential for
results to be clear and meaningful so they can be interpreted
by staff in terms of the clinical picture. Therefore, curriculums
for microbiology and infection, public health and IPC training
should also incorporate basic training on interpretation of WGS
results.
Based on the authors’ experience of using real-time WGS for
outbreak investigations, instances in which increased WGS
discriminatory power and phylogenetic analysis is required
have been identified (Figure 2). There continues to be a sig-
nificant cost to sequencing, and using WGS for the investigation
of all outbreaks is not likely to be feasible for the foreseeable
future. The discriminatory power of WGS was particularly val-
uable in outbreak situations with new or unusual resistance
mechanisms. The majority of outbreaks required a medium
level of WGS discriminatory power to determine if isolates
were related. In instances where the epidemiology demon-
strated that there was likely to be an outbreak, less WGS dis-
crimination was required.
Considering the findings, it is suggested that there could be
different approaches to the use of WGS for outbreak detection
(Figure 3). The first approach involves a reactive automated
response to epidemiology suggestive of an outbreak. In this
instance, phenotypic methods may suggest that there is an
outbreak and isolates could then undergo WGS. An alternative
to this is a proactive approach in which WGS is used to detect
an outbreak regardless of epidemiology. In these instances,
users of WGS could prospectively sequence select populations
of patients who may be vulnerable to infection who may be
from a critical location, such as a neonatal ICU, or focus upon
sequencing a highly resistant or virulent organism from patient
samples or the environment. Sequencing a specific group of
micro-organisms that cause nosocomial infections in a com-
plete geographic area can give a high-resolution view of the
pathogen population that can pinpoint the genetic basis of
resistance and spread of the pathogen. This would represent a
shift in the identification of outbreaks. A reflective approach to
outbreak investigations could include the use of WGS in defined
instances, when there is missing epidemiological data or in
scenarios in which phenotypic testing lacks granularity.
A clinical decision aid (Figure 4) has been developed to assist
clinicians in selecting isolates for sequencing, and actions fol-
lowing the production of results. The speed at which outbreaks
emerge differs by organism and in accordance with the micro-
organism’s ecology or clinical setting. Clustered organisms can
arise sufficiently far apart in time or location that they are not
identified; therefore, local surveillance systems should be set
to have a trigger/threshold that prompts IPC action. It is sug-
gested that the process of outbreak identification should be
automated by developing systems that function without human
coordination with set ‘action line’ rules. This can be brought
about by collecting epidemiological data, using SPC charts and
implementing outbreak surveillance software such as ICNet.
Care needs to be taken in relation to the interpretation of
results, particularly with regard to the meaning of SNPdifferences. These need to be considered in the context of
pathogen genome stability and the environment. For instance,
the literature reports that various SNP differences have been
found during the investigation of listeria outbreaks, with
diversity ranging from zero to five SNPs and, in some outbreaks,
up to 42 SNPs [27]. At the time when the authors investigated
the listeria outbreak, Public Health England observed that lis-
teria isolates in outbreaks linked to a single food premises can
be as many as 20 SNPs apart, which is in contrast to findings in
verocytotoxigenic E. coli and salmonella incidents, where only
isolates within five SNPs of each other would be considered to
be linked. This is because Listeria spp. can remain as envi-
ronmental contaminants in premises over many years (G.
Hawkins, Health Protection Scotland, Personal Communica-
tion, 1 September 2016).
WGS can be an asset at every stage of outbreak manage-
ment, assisting IPCTs in the formulation of case definitions and
supporting or refuting hypotheses in relation to lines of trans-
mission. When coupled with epidemiological data, WGS can
provide the ultimate discrimination of results, enabling IPCTs
to carry out outbreak investigations efficiently and effectively.
Its value also lies in testing the effectiveness of IPC measures
and being able to rule out outbreaks, which negates the
requirement for outbreak meetings and disruption to health-
care services. With the global threat of dissemination of anti-
microbial resistance, WGS is a valuable tool that should be used
to generate greater understanding of the development of new
resistance mechanisms and dissemination of resistance ele-
ments. In the authors’ opinion, the benefits of using WGS for
outbreak investigation that have been encountered since
establishment of a clinical WGS service in 2014 have far out-
weighed the efforts to confront the challenges of implementing
this technology into routine care.
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